We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Elanco Animal Health Incorporated | NYSE:ELAN | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.06 | 0.45% | 13.53 | 13.77 | 13.41 | 13.73 | 3,719,972 | 01:00:00 |
From May 2019 to May 2024
By Olivia Bugault
Bayer AG said Tuesday that it will raise roughly $1.65 billion through the placement of Elanco Animal Health Inc. shares.
The German chemical and pharmaceutical conglomerate said that it will place 54.5 million Elanco shares at a price of $30.25 each.
"Bayer has granted the underwriters a 30-day option to purchase up to an additional 8.175 million Elanco shares on the same terms and conditions," the company said.
In August, Bayer completed the sale of its animal health business unit to U.S.-based company Elanco and received 72.9 million Elanco shares corresponding to roughly 15.5% of the company's outstanding shares.
"As previously announced, Bayer intends to divest the remaining stake in Elanco in due course," Bayer said.
Write to Olivia Bugault at olivia.bugault@wsj.com
(END) Dow Jones Newswires
December 01, 2020 02:00 ET (07:00 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Elanco Animal Health Chart |
1 Month Elanco Animal Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
